CNBX Pharmaceuticals

Cannabinoid-based anti tumor Drug Candidate for the treatment of Colorectal Cancer

CNBX Pharmaceuticals is a publicly traded company (CNBX: OTCQB) and developer of the world’s first cannabinoid-based antitumor drug candidate for the treatment of colorectal cancer based on the company's novel and proprietary formulation CNBX� RCC-33.